Pembrolizumab as first line treatment of Merkel cell carcinoma patients – a case series of patients with various co-morbidities

Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer associated with a high mortality rate in advanced stages [1,2]. For patients with non-resectable advanced/meta...